In summary, comparing tumor growth in NSG and C57BL/6 mice, our results indicate that genetic and pharmacological attenuation of YAP1 significantly inhibits the tumor development in immune-competent and NSG mice. The gene discussed is YAP1; the disease is neoplasm.